Sally Armstrong
|
CEO PRAXIS
As CEO of PRAXIS Australia, Sally leads the design and delivery of collaborative training solutions for the clinical trials, research and research ethics sectors. This includes the current partnership between PRAXIS and Health NZ |Te Whatu Ora.
Sally is a skilled leader, project and partnerships director with over 25 years of experience working across global government, industry and academic organisations. Her experience spans diverse sectors including education, training, biotech, science, health and the pharmaceutical sectors. Recent roles have included leading the Victorian public-private partnership office for the world’s largest healthcare provider, a leading university and a government department. |
|
Sally is an experienced Director, having held these positions for two successful consulting organisations that delivered national and global training solutions for global organisations including BHP Billiton, Amcor, Pacific Brands, CSIRO and 18 government departments and agencies (State and Federal).
She is a Graduate of the Australian Institute of Company Directors (GAICD), and holds a Master of Education, Bachelor of Arts and Certificate IV in Training & Assessment.
Sally is excited to attend her second NZACRes Conference. She loves everything about New Zealand – and is partial to Kapiti Ice Cream and Devonport Chocolate.
She is a Graduate of the Australian Institute of Company Directors (GAICD), and holds a Master of Education, Bachelor of Arts and Certificate IV in Training & Assessment.
Sally is excited to attend her second NZACRes Conference. She loves everything about New Zealand – and is partial to Kapiti Ice Cream and Devonport Chocolate.
Empowering Aotearoa: New Clinical Trials Courses Tailored for New Zealand
Discover a transformative leap in clinical research education with the newly launched courses for New Zealand —an initiative born from a pivotal conversation at the last NZACRes Conference. This collaboration between PRAXIS Australia and Health New Zealand | Te Whatu Ora has culminated in a suite of courses designed to meet the unique needs of New Zealand's clinical trials and research sectors.
These courses are not mere adaptations; they are comprehensive programs that integrate New Zealand's regulatory frameworks, the principles of the Treaty of Waitangi, and cultural safety awareness. Whether you're a newcomer to clinical research or a seasoned professional learn how tailored tools can offer flexible, on-demand learning, ensuring accessibility across the nation.
In this session, we'll delve into the genesis of this Trans-Tasman collaboration, exploring how a shared vision evolved into a tangible educational resource. We'll share insights from the initial pilot programs launched earlier this year, including feedback from participants and the measurable impact on their professional practice.
Join us to understand how this initiative is not only enhancing individual competencies but also strengthening the broader research ecosystem in Aotearoa. Be part of the conversation on how tailored education can drive excellence and equity in clinical research.
These courses are not mere adaptations; they are comprehensive programs that integrate New Zealand's regulatory frameworks, the principles of the Treaty of Waitangi, and cultural safety awareness. Whether you're a newcomer to clinical research or a seasoned professional learn how tailored tools can offer flexible, on-demand learning, ensuring accessibility across the nation.
In this session, we'll delve into the genesis of this Trans-Tasman collaboration, exploring how a shared vision evolved into a tangible educational resource. We'll share insights from the initial pilot programs launched earlier this year, including feedback from participants and the measurable impact on their professional practice.
Join us to understand how this initiative is not only enhancing individual competencies but also strengthening the broader research ecosystem in Aotearoa. Be part of the conversation on how tailored education can drive excellence and equity in clinical research.
